COMMUNIQUÉ DE PRESSE publié le 29/03/2025 à 00:57, il y a 1 année 7 mois EQS-Adhoc: Bondholders, minority shareholder and Management Board of ACCENTRO reach agreement in principle on comprehensive restructuring solution ACCENTRO Real Estate AG and stakeholders agree on comprehensive restructuring solution, including bondholder agreement and equity restructuring plan Real Estate Restructuring Bondholders Equity ACCENTRO
COMMUNIQUÉ DE PRESSE publié le 28/03/2025 à 22:25, il y a 1 année 7 mois EQS-Adhoc: Mynaric AG: Resignation of Bulent Altan as Chairman and Member of Supervisory Board Mynaric AG announces resignation of Bulent Altan as Chairman and Member of Supervisory Board due to personal reasons, with new elections to follow. Company specializes in laser communication terminals for air, space, and mobile applications Resignation Mynaric AG Laser Communication Elections Bulent Altan
COMMUNIQUÉ RÉGLEMENTÉ publié le 28/03/2025 à 22:00, il y a 1 année 7 mois Biophytis annonce le règlement-livraison de son placement privé de 2,6 millions d'euros Biophytis annonce le règlement-livraison de son placement privé de 2,6 millions d'euros. Les actions seront cotées sur Euronext Growth. Maxim Group LLC et Invest Securities ont agi en tant qu'agents de placement Biophytis Placement Privé Euronext Growth INVEST SECURITIES Maxim Group LLC
COMMUNIQUÉ RÉGLEMENTÉ publié le 28/03/2025 à 22:00, il y a 1 année 7 mois Biophytis announces the settlement and delivery of its €2.6 million private placement Biophytis announces the settlement and delivery of its €2.6 million private placement. New shares admitted for trading on Euronext Growth. Maxim Group LLC and Invest Securities involved in the transaction Private Placement Biophytis Euronext Growth Maxim Group LLC Settlement
COMMUNIQUÉ DE PRESSE publié le 28/03/2025 à 22:00, il y a 1 année 7 mois Electric Metals Announces Marketing Agreement With NAI Interactive Electric Metals (USA) Limited announces marketing agreement with NAI Interactive Ltd. to translate materials into Mandarin and distribute to over 30,000 members TSX Venture Exchange Electric Metals Marketing Agreement NAI Interactive Mandarin Translation
COMMUNIQUÉ DE PRESSE publié le 28/03/2025 à 22:00, il y a 1 année 7 mois GMV Minerals Announces Extension of Expiry Date for Warrants GMV Minerals Inc. applies to extend expiry date for common share purchase warrants on TSXV. Company focused on developing precious metal assets in Arizona TSX Venture Exchange Arizona Common Share Purchase Warrants GMV Minerals Inc. Precious Metal Assets
COMMUNIQUÉ DE PRESSE publié le 28/03/2025 à 21:59, il y a 1 année 7 mois Biophytis annonce le règlement-livraison de son placement privé de 2,6 millions d'euros Biophytis annonce le règlement-livraison de son placement privé de 2,6 millions d'euros. Actions nouvelles admises à Euronext Growth Paris Euronext Growth Paris Biophytis Placement Privé Actions Nouvelles 2,6 Millions D'euros
COMMUNIQUÉ DE PRESSE publié le 28/03/2025 à 21:59, il y a 1 année 7 mois Biophytis announces the settlement and delivery of its €2.6 million private placement Biophytis settles €2.6 million private placement, issuing new shares and warrants. Company specializes in age-related disease treatments Private Placement Biophytis Warrants New Shares Age-related Diseases
COMMUNIQUÉ DE PRESSE publié le 28/03/2025 à 21:10, il y a 1 année 7 mois ALT5 Sigma Reports Strong Q4 and Full-Year 2024 Results, Achieves Milestones with Record Revenue, 1,000+ Customers, and Strategic Leadership Appointments ALT5 Sigma Corp achieves record-breaking Q4 with $5.4 million revenue, surpasses 1,000 customer milestone, and appoints Ron Pitters as COO. Financial results and key developments highlighted Financial Results ALT5 Sigma Corp Record-breaking Q4 Revenue Milestone Leadership Developments
COMMUNIQUÉ DE PRESSE publié le 28/03/2025 à 21:07, il y a 1 année 7 mois Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors Qfitlia (fitusiran) approved as the first US therapy for hemophilia A or B with or without inhibitors, offering consistent protection with few injections, using unique mechanism to reduce bleeding episodes Fitusiran Hemophilia Qfitlia Antithrombin-lowering Therapy Bleed Protection
Publié le 20/11/2026 à 18:34, il y a 1 jour 7 heures Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Publié le 20/11/2026 à 18:34, il y a 1 jour 7 heures Disclosure of transactions in own shares from November 16 to November 20, 2026
Publié le 20/11/2026 à 17:35, il y a 1 jour 8 heures Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Publié le 20/11/2026 à 17:35, il y a 1 jour 8 heures Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Publié le 19/11/2026 à 19:00, il y a 2 jours 7 heures MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR
Publié le 20/11/2026 à 15:00, il y a 1 jour 11 heures Jaguar Health, Inc. Announces Reverse Stock Split
Publié le 20/11/2026 à 14:50, il y a 1 jour 11 heures Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Publié le 20/11/2026 à 14:00, il y a 1 jour 12 heures Dateline appoints Tony Ferguson as Acting Chairman
Publié le 20/11/2026 à 13:30, il y a 1 jour 12 heures Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Publié le 20/11/2026 à 13:30, il y a 1 jour 12 heures Alset AI Closes Non-Brokered Private Placement Offering
Publié le 20/11/2026 à 23:45, il y a 1 jour 2 heures APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Publié le 20/11/2026 à 22:39, il y a 1 jour 3 heures ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Publié le 20/11/2026 à 21:36, il y a 1 jour 4 heures EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Publié le 20/11/2026 à 20:49, il y a 1 jour 5 heures E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF